Custom synthesis | Naphthyridine | Pyrimidine | Indoline |
Antidepressants

Tadalafil 171596-29-5

Tadalafil is PDE5 inhibitor for treating erectile dysfunction (ED), and for the treatment of pulmonary arterial hypertension. In October 2011 the U.S. Food and Drug Administration (FDA) approved Cialis for treating the signs and symptoms of benign prostatic hyperplasia (BPH) as well as a combination of BPH and erectile dysfunction (ED) when the conditions coincide.

Tadalafil 171596-29-5
Tadalafil 171596-29-5
Appearance:White powder
Cas No:171596-29-5
EINECS:NA
Formula:C22H19N3O4
Molecular Weight:389.40
Melting Point:298-300 °C
Boiling Point:679.1 °C
Flash Point: 364.5 °C
Usage:ED
Testing Items
Standards:Enterprise
Appearance
White to off-white crystalline powder
Identification
should conform
Purity
NLT98%

GMP for Tadalafil 171596-29-5 is not available.
 
Disclaimer:Those products (Tadalafil 171596-29-5) are for lab analytical & research purposes only.